MDGL logo

Madrigal Pharmaceuticals (MDGL) CAPEX

Annual CAPEX

N/A

December 31, 2023

Summary

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

MDGL CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$4.88 M
MDGL annual capital expenditures is currently at an all-time high

3-Year Low

-
MDGL annual capital expenditures 3-year low is unknown

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
MDGL previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 26, 2025
MDGL next annual earnings announcement is scheduled for Feb 26, 2025

OtherMDGLcash flowmetrics:

Annual FCF

-$325.71 M
MDGL annual free cash flow is -$325.71 million

Annual CFO

-$324.23 M
MDGL annual cash flow from operations is -$324.23 million

Annual CFI

-$502.52 M
MDGL annual cash flow from investing activities is -$502.52 million

Annual CFF

$595.12 M
MDGL annual cash flow from financing activities is $595.12 million

Quarterly CAPEX

$779.00 K
-$4.35 M-84.82%

September 30, 2024

Summary

Performance

3-Month Change

-84.82%

1-Year Change

-84.82%

3-Year Change

-84.82%

5-Year Change

-84.82%

MDGL Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

52.27%
MDGL quarterly capital expenditures is higher than 52.27% of companies in Healthcare sector

High & Low

All-time High

$5.13 M
MDGL quarterly capital expenditures is currently -84.82% below its historical high of $5.13 million

3-Year Low

$29.00 K
MDGL quarterly capital expenditures is currently +2586.21% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MDGL previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 26, 2025
MDGL next earnings announcement is scheduled for Feb 26, 2025

OtherMDGLcash flowmetrics:

Quarterly FCF

-$67.76 M
MDGL quarterly free cash flow is -$67.76 million

Quarterly CFO

-$66.98 M
MDGL quarterly cash flow from operations is -$66.98 million

Quarterly CFI

-$202.39 M
MDGL quarterly cash flow from investing activities is -$202.39 million

Quarterly CFF

$7.46 M
MDGL quarterly cash flow from financing activities is $7.46 million

TTM CAPEX

$7.30 M
+$440.00 K+6.41%

September 30, 2024

Summary

Performance

3-Month Change

+6.41%

1-Year Change

+6.41%

3-Year Change

+6.41%

5-Year Change

+6.41%

MDGL TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

60.91%
MDGL TTM capital expenditures is higher than 60.91% of companies in Healthcare sector

High & Low

All-time High

$7.30 M
MDGL TTM capital expenditures is currently at an all-time high

3-Year Low

$166.00 K
MDGL TTM capital expenditures is currently +4299.40% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MDGL previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 26, 2025
MDGL next earnings announcement is scheduled for Feb 26, 2025

OtherMDGLcash flowmetrics:

TTM FCF

-$438.32 M
MDGL TTM free cash flow is -$438.32 million

TTM CFO

-$431.02 M
MDGL TTM cash flow from operations is -$431.02 million

TTM CFI

-$588.56 M
MDGL TTM cash flow from investing activities is -$588.56 million

TTM CFF

$1.20 B
MDGL TTM cash flow from financing activities is $1.20 billion

MDGL CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year--84.8%+6.4%
3 y3 years--84.8%+6.4%
5 y5 years--84.8%+6.4%

MDGL CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-84.8%+2586.2%at high+4299.4%
5 y5-year-84.8%>+9999.0%at high>+9999.0%
alltimeall time-84.8%+1398.3%at high>+9999.0%

Madrigal Pharmaceuticals CAPEX History

DateAnnualQuarterlyTTM
Sep 2024
-
$779.00 K(-84.8%)
$7.30 M(+6.4%)
Jun 2024
-
$5.13 M(+1337.3%)
$6.86 M(+281.1%)
Mar 2024
-
$357.00 K(-65.5%)
$1.80 M(+21.8%)
Dec 2023
-
$1.04 M(+205.6%)
$1.48 M(+213.3%)
Sep 2023
-
$339.00 K(+391.3%)
$472.00 K(+184.3%)
Jun 2023
-
$69.00 K(+97.1%)
$166.00 K(-17.0%)
Mar 2023
-
$35.00 K(+20.7%)
$200.00 K(-7.8%)
Dec 2022
-
$29.00 K(-12.1%)
$217.00 K(-27.9%)
Sep 2022
-
$33.00 K(-68.0%)
$301.00 K(-5.3%)
Jun 2022
-
$103.00 K(+98.1%)
$318.00 K(+46.5%)
Mar 2022
-
$52.00 K(-54.0%)
$217.00 K(+3.8%)
Dec 2021
-
$113.00 K(+126.0%)
$209.00 K(+97.2%)
Sep 2021
-
$50.00 K(+2400.0%)
$106.00 K(+79.7%)
Jun 2021
-
$2000.00(-95.5%)
$59.00 K(-7.8%)
Mar 2021
-
$44.00 K(+340.0%)
$64.00 K(-80.8%)
Dec 2020
-
$10.00 K(+233.3%)
$334.00 K(-27.1%)
Sep 2020
-
$3000.00(-57.1%)
$458.00 K(+1.1%)
Jun 2020
-
$7000.00(-97.8%)
$453.00 K(+1.8%)
Mar 2020
-
$314.00 K(+134.3%)
$445.00 K(+158.7%)
Dec 2019
-
$134.00 K(-6800.0%)
$172.00 K(+273.9%)
Sep 2019
-
-$2000.00(+100.0%)
$46.00 K(-24.6%)
Jun 2019
-
-$1000.00(-102.4%)
$61.00 K(-1.6%)
Mar 2019
-
$41.00 K(+412.5%)
$62.00 K(+181.8%)
Dec 2018
-
$8000.00(-38.5%)
$22.00 K(+57.1%)
Sep 2018
-
$13.00 K(>+9900.0%)
$14.00 K(+1300.0%)
Jun 2018
-
$0.00(-100.0%)
$1000.00(-99.2%)
Mar 2018
-
$1000.00(>+9900.0%)
$124.00 K(-0.8%)
Dec 2017
-
$0.00(0.0%)
$125.00 K(-1.6%)
Sep 2017
-
$0.00(-100.0%)
$127.00 K(-0.8%)
Jun 2017
-
$123.00 K(+6050.0%)
$128.00 K(+2460.0%)
Mar 2017
-
$2000.00(0.0%)
$5000.00(+66.7%)
Dec 2016
-
$2000.00(+100.0%)
$3000.00(+200.0%)
Sep 2016
-
$1000.00(-103.7%)
$1000.00(-98.3%)
Sep 2015
-
-$27.00 K(-200.0%)
$59.00 K(-52.0%)
Jun 2015
-
$27.00 K(-54.2%)
$123.00 K(-14.6%)
DateAnnualQuarterlyTTM
Dec 2014
-
$59.00 K(+59.5%)
$144.00 K(-13.8%)
Sep 2014
-
$37.00 K(+48.0%)
$167.00 K(+14.4%)
Jun 2014
-
$25.00 K(+8.7%)
$146.00 K(-71.7%)
Mar 2014
-
$23.00 K(-72.0%)
$516.00 K(-32.9%)
Dec 2013
-
$82.00 K(+412.5%)
$769.00 K(-0.3%)
Sep 2013
-
$16.00 K(-95.9%)
$771.00 K(-20.0%)
Jun 2013
-
$395.00 K(+43.1%)
$964.00 K(+52.1%)
Mar 2013
-
$276.00 K(+228.6%)
$634.00 K(+25.5%)
Dec 2012
$505.00 K(-26.8%)
$84.00 K(-59.8%)
$505.00 K(-37.1%)
Sep 2012
-
$209.00 K(+221.5%)
$803.00 K(-6.3%)
Jun 2012
-
$65.00 K(-55.8%)
$857.00 K(+3.6%)
Mar 2012
-
$147.00 K(-61.5%)
$827.00 K(+19.9%)
Dec 2011
$690.00 K(+407.4%)
$382.00 K(+45.2%)
$690.00 K(+106.0%)
Sep 2011
-
$263.00 K(+651.4%)
$335.00 K(+135.9%)
Jun 2011
-
$35.00 K(+250.0%)
$142.00 K(-2.7%)
Mar 2011
-
$10.00 K(-63.0%)
$146.00 K(+7.4%)
Dec 2010
$136.00 K(-70.0%)
$27.00 K(-61.4%)
$136.00 K(+177.6%)
Sep 2010
-
$70.00 K(+79.5%)
$49.00 K(+390.0%)
Jun 2010
-
$39.00 K(-165.0%)
$10.00 K(-97.8%)
Dec 2009
$454.00 K(-79.2%)
-$60.00 K(-293.5%)
$454.00 K(-64.1%)
Sep 2009
-
$31.00 K(-69.3%)
$1.26 M(-24.6%)
Jun 2009
-
$101.00 K(-73.6%)
$1.68 M(-22.8%)
Mar 2009
-
$382.00 K(-49.0%)
$2.17 M(-0.6%)
Dec 2008
$2.18 M(-7.1%)
$749.00 K(+68.7%)
$2.18 M(-5.1%)
Sep 2008
-
$444.00 K(-25.5%)
$2.30 M(-8.6%)
Jun 2008
-
$596.00 K(+50.9%)
$2.52 M(+11.8%)
Mar 2008
-
$395.00 K(-54.4%)
$2.25 M(-4.2%)
Dec 2007
$2.35 M(+48.7%)
$866.00 K(+31.2%)
$2.35 M(+58.4%)
Sep 2007
-
$660.00 K(+99.4%)
$1.48 M(+80.1%)
Jun 2007
-
$331.00 K(-32.9%)
$824.00 K(+67.1%)
Mar 2007
-
$493.00 K(-40.6%)
$493.00 K(-40.6%)
Dec 2006
$1.58 M(-67.6%)
-
-
Dec 2005
$4.88 M(+206.3%)
-
-
Mar 2005
-
$830.00 K
$830.00 K
Dec 2004
$1.59 M(+107.3%)
-
-
Dec 2003
$769.00 K
-
-

FAQ

  • What is the all time high annual CAPEX for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals quarterly CAPEX year-on-year change?
  • What is Madrigal Pharmaceuticals TTM capital expenditures?
  • What is the all time high TTM CAPEX for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals TTM CAPEX year-on-year change?

What is the all time high annual CAPEX for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high annual capital expenditures is $4.88 M

What is Madrigal Pharmaceuticals quarterly capital expenditures?

The current quarterly CAPEX of MDGL is $779.00 K

What is the all time high quarterly CAPEX for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high quarterly capital expenditures is $5.13 M

What is Madrigal Pharmaceuticals quarterly CAPEX year-on-year change?

Over the past year, MDGL quarterly capital expenditures has changed by -$4.35 M (-84.82%)

What is Madrigal Pharmaceuticals TTM capital expenditures?

The current TTM CAPEX of MDGL is $7.30 M

What is the all time high TTM CAPEX for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high TTM capital expenditures is $7.30 M

What is Madrigal Pharmaceuticals TTM CAPEX year-on-year change?

Over the past year, MDGL TTM capital expenditures has changed by +$440.00 K (+6.41%)